ARDENT HEALTH INC (ARDT) Stock Fundamental Analysis

NYSE:ARDT • US03980N1072

9.41 USD
-0.07 (-0.74%)
At close: Mar 3, 2026
9.41 USD
0 (0%)
After Hours: 3/3/2026, 4:52:23 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, ARDT scores 5 out of 10 in our fundamental rating. ARDT was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of ARDT get a neutral evaluation. Nothing too spectacular is happening here. ARDT scores decently on growth, while it is valued quite cheap. This could make an interesting combination. This makes ARDT very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • ARDT had positive earnings in the past year.
  • ARDT had a positive operating cash flow in the past year.
ARDT Yearly Net Income VS EBIT VS OCF VS FCFARDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

  • ARDT has a Return On Assets of 3.98%. This is in the better half of the industry: ARDT outperforms 71.29% of its industry peers.
  • ARDT has a better Return On Equity (16.56%) than 84.16% of its industry peers.
  • The Return On Invested Capital of ARDT (7.53%) is better than 69.31% of its industry peers.
  • ARDT had an Average Return On Invested Capital over the past 3 years of 5.96%. This is below the industry average of 9.13%.
  • The last Return On Invested Capital (7.53%) for ARDT is above the 3 year average (5.96%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.98%
ROE 16.56%
ROIC 7.53%
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
ARDT Yearly ROA, ROE, ROICARDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • ARDT's Profit Margin of 3.24% is fine compared to the rest of the industry. ARDT outperforms 70.30% of its industry peers.
  • ARDT's Profit Margin has improved in the last couple of years.
  • The Operating Margin of ARDT (5.98%) is better than 68.32% of its industry peers.
  • ARDT's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 57.94%, ARDT belongs to the top of the industry, outperforming 81.19% of the companies in the same industry.
  • ARDT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.98%
PM (TTM) 3.24%
GM 57.94%
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
ARDT Yearly Profit, Operating, Gross MarginsARDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • ARDT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ARDT has more shares outstanding
  • ARDT has a better debt/assets ratio than last year.
ARDT Yearly Shares OutstandingARDT Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M
ARDT Yearly Total Debt VS Total AssetsARDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • ARDT has an Altman-Z score of 2.04. This is not the best score and indicates that ARDT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ARDT (2.04) is comparable to the rest of the industry.
  • ARDT has a debt to FCF ratio of 7.03. This is a slightly negative value and a sign of low solvency as ARDT would need 7.03 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 7.03, ARDT perfoms like the industry average, outperforming 55.45% of the companies in the same industry.
  • ARDT has a Debt/Equity ratio of 0.88. This is a neutral value indicating ARDT is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ARDT (0.88) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 7.03
Altman-Z 2.04
ROIC/WACC0.95
WACC7.9%
ARDT Yearly LT Debt VS Equity VS FCFARDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • ARDT has a Current Ratio of 2.08. This indicates that ARDT is financially healthy and has no problem in meeting its short term obligations.
  • ARDT's Current ratio of 2.08 is amongst the best of the industry. ARDT outperforms 81.19% of its industry peers.
  • ARDT has a Quick Ratio of 1.95. This is a normal value and indicates that ARDT is financially healthy and should not expect problems in meeting its short term obligations.
  • ARDT's Quick ratio of 1.95 is amongst the best of the industry. ARDT outperforms 81.19% of its industry peers.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 1.95
ARDT Yearly Current Assets VS Current LiabilitesARDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • ARDT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 314.38%, which is quite impressive.
  • ARDT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.75% yearly.
  • Looking at the last year, ARDT shows a quite strong growth in Revenue. The Revenue has grown by 10.29% in the last year.
  • Measured over the past years, ARDT shows a small growth in Revenue. The Revenue has been growing by 7.00% on average per year.
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%205.88%
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%8.75%

3.2 Future

  • Based on estimates for the next years, ARDT will show a small growth in Earnings Per Share. The EPS will grow by 6.74% on average per year.
  • ARDT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.17% yearly.
EPS Next Y-20.46%
EPS Next 2Y5.57%
EPS Next 3Y6.74%
EPS Next 5YN/A
Revenue Next Year8.67%
Revenue Next 2Y6.69%
Revenue Next 3Y6.36%
Revenue Next 5Y7.17%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ARDT Yearly Revenue VS EstimatesARDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
ARDT Yearly EPS VS EstimatesARDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 4.40, the valuation of ARDT can be described as very cheap.
  • Based on the Price/Earnings ratio, ARDT is valued cheaper than 98.02% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.83, ARDT is valued rather cheaply.
  • ARDT is valuated cheaply with a Price/Forward Earnings ratio of 6.87.
  • Based on the Price/Forward Earnings ratio, ARDT is valued cheaply inside the industry as 96.04% of the companies are valued more expensively.
  • ARDT is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.95, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.4
Fwd PE 6.87
ARDT Price Earnings VS Forward Price EarningsARDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ARDT is valued cheaply inside the industry as 97.03% of the companies are valued more expensively.
  • ARDT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ARDT is cheaper than 86.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.56
EV/EBITDA 3.49
ARDT Per share dataARDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The decent profitability rating of ARDT may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.57%
EPS Next 3Y6.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ARDT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ARDENT HEALTH INC

NYSE:ARDT (3/3/2026, 4:52:23 PM)

After market: 9.41 0 (0%)

9.41

-0.07 (-0.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-12
Earnings (Next)03-04
Inst Owners74.95%
Inst Owner Change-0.36%
Ins Owners1.98%
Ins Owner Change-0.01%
Market Cap1.35B
Revenue(TTM)6.33B
Net Income(TTM)205.06M
Analysts77.89
Price Target13.98 (48.57%)
Short Float %2.32%
Short Ratio6.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)48.03%
Min EPS beat(2)24.85%
Max EPS beat(2)71.2%
EPS beat(4)4
Avg EPS beat(4)53.83%
Min EPS beat(4)24.85%
Max EPS beat(4)76.2%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.13%
Min Revenue beat(2)-0.08%
Max Revenue beat(2)4.33%
Revenue beat(4)2
Avg Revenue beat(4)2.08%
Min Revenue beat(4)-2.01%
Max Revenue beat(4)6.1%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.18%
PT rev (3m)-15.64%
EPS NQ rev (1m)12.34%
EPS NQ rev (3m)-18.4%
EPS NY rev (1m)-0.8%
EPS NY rev (3m)-47.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE 4.4
Fwd PE 6.87
P/S 0.21
P/FCF 8.56
P/OCF 3.68
P/B 1.09
P/tB 4.98
EV/EBITDA 3.49
EPS(TTM)2.14
EY22.74%
EPS(NY)1.37
Fwd EY14.56%
FCF(TTM)1.1
FCFY11.69%
OCF(TTM)2.56
OCFY27.21%
SpS44.18
BVpS8.65
TBVpS1.89
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.41
Profitability
Industry RankSector Rank
ROA 3.98%
ROE 16.56%
ROCE 8.99%
ROIC 7.53%
ROICexc 8.81%
ROICexgc 12.04%
OM 5.98%
PM (TTM) 3.24%
GM 57.94%
FCFM 2.49%
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
ROICexc(3y)6.85%
ROICexc(5y)N/A
ROICexgc(3y)9.47%
ROICexgc(5y)N/A
ROCE(3y)7.12%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
F-Score8
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 7.03
Debt/EBITDA 2.05
Cap/Depr 137.15%
Cap/Sales 3.31%
Interest Coverage 250
Cash Conversion 69.06%
Profit Quality 76.79%
Current Ratio 2.08
Quick Ratio 1.95
Altman-Z 2.04
F-Score8
WACC7.9%
ROIC/WACC0.95
Cap/Depr(3y)111.7%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.88%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%205.88%
EPS Next Y-20.46%
EPS Next 2Y5.57%
EPS Next 3Y6.74%
EPS Next 5YN/A
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%8.75%
Revenue Next Year8.67%
Revenue Next 2Y6.69%
Revenue Next 3Y6.36%
Revenue Next 5Y7.17%
EBIT growth 1Y87.99%
EBIT growth 3Y10.2%
EBIT growth 5YN/A
EBIT Next Year53.07%
EBIT Next 3Y17.14%
EBIT Next 5YN/A
FCF growth 1Y51.28%
FCF growth 3Y152.66%
FCF growth 5YN/A
OCF growth 1Y42.1%
OCF growth 3Y28.95%
OCF growth 5YN/A

ARDENT HEALTH INC / ARDT FAQ

Can you provide the ChartMill fundamental rating for ARDENT HEALTH INC?

ChartMill assigns a fundamental rating of 5 / 10 to ARDT.


Can you provide the valuation status for ARDENT HEALTH INC?

ChartMill assigns a valuation rating of 8 / 10 to ARDENT HEALTH INC (ARDT). This can be considered as Undervalued.


Can you provide the profitability details for ARDENT HEALTH INC?

ARDENT HEALTH INC (ARDT) has a profitability rating of 6 / 10.


Can you provide the financial health for ARDT stock?

The financial health rating of ARDENT HEALTH INC (ARDT) is 5 / 10.